Unicorn Biotechnologies, founded in 2020, is a promising player in the Biotechnology industry based in the United Kingdom. Their mission, encapsulated in the slogan "Liberating scientists & scaling cell biology," focuses on reducing the burdensome manual tasks that stifle biologists.
The company has developed intelligent machines designed to streamline the workflow in biological research, effectively removing time-consuming manual labor from the equation. This innovation not only accelerates scientific research but also offers clear pathways for innovations to transition from the lab bench to industrial-scale production.
In its recent financial round, Unicorn Biotechnologies secured a $3.20M Seed Round on April 21, 2022, backed by notable investors such as SOSV, HAX, Marinya Capital, and others. This funding positions the company well for future growth and further advancement of their pioneering technologies.